Zobrazeno 1 - 10
of 272
pro vyhledávání: '"Diabetes Mellitus"'
Publikováno v:
Current Medical Research and Opinion. 38:1831-1840
To evaluate incidence of stroke, myocardial infarction (MI), and peripheral artery disease (PAD) in patients with type 2 diabetes mellitus (T2DM) and assess associated health care resource utilization (HCRU) and costs in the United States. Patients
Autor:
Behnaz Abiri, Amirhossein Ramezani Ahmadi, Amir Ebadinejad, Farhad Hosseinpanah, Majid Valizadeh
Publikováno v:
Current medical research and opinion. 38(11)
To identify the impact of sodium-glucose co-transporter-2Clinical trials investigating the safety and efficacy of SGLT2 inhibitors in overweight or obese adults were sought in PubMed, Scopus, Google Scholar, and EMBASE databases. The overall interven
Publikováno v:
Current Medical Research and Opinion. 36:1985-1989
Sodium-glucose cotransporter-2 (SGLT2) inhibitor has been linked to an increased risk of lower extremity amputation (LEA) in patients with Type 2 Diabetes (T2D) and is known to induce volume depletion through osmotic diuresis. We investigated the pot
Autor:
Manreet Kanwar, Sumeet Panjabi, Ameur M. Manceur, Marjolaine Gauthier-Loiselle, Patrick Lefebvre, Raymond L. Benza, Yuen Tsang, Michele R. Cole
Publikováno v:
Current Medical Research and Opinion. 37:1483-1491
OBJECTIVE Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare disease that often follows pulmonary embolism (PE). Screening for CTEPH is challenging, often delaying diagnosis and worsening prognosis. Predictive risk models for CTEPH could
Autor:
Irene Romera, Silvia Díaz-Cerezo, Tatiana Dilla, Antoni Sicras-Mainar, Esther Artime, Flora López-Simarro, Jesús Reviriego
Publikováno v:
Current Medical Research and Opinion. 36:1449-1456
To compare healthcare resource use (HRU) and annual costs in type 2 diabetes mellitus (T2DM) patients with poor glycaemic control and obesity versus good glycaemic control without obesity.Observational retrospective study based on the analysis of ele
Autor:
Zhong Yuan, Rose Qiu, Amy Freedman, James Weaver, Lu Wang, Laura Hester, Jesse A. Berlin, Frank J. DeFalco, Joel N. Swerdel, Patrick B. Ryan, Jacqueline Yee, Norman Rosenthal, Martijn J. Schuemie, Gary Meininger
Publikováno v:
Current Medical Research and Opinion. 36:1117-1124
Objective: Observational evidence suggests that patients with type 2 diabetes mellitus (T2DM) are at increased risk for acute pancreatitis (AP) versus those without T2DM. A small number of AP events were reported in clinical trials of the sodium gluc
Autor:
Lihui Zhang, Ziling Li, Shandong Ye, Ying Zhang, Yanli Huang, Xinling Wang, Shiying Shao, Hongyan Deng, Mingbiao Shi, Yushan Guo, Xiangjin Xu, Xuefeng Li, Feng Li, Jun Yao, Xiaomei Zhang, Yongde Peng, Yuan Jing, Xiaoyue Wang, Wei Wang, Xiaohui Guo, Weijuan Liu, Guijun Qin, Mengya Cao, Xinhua Xiao, Jing Dou, Zhongyuan Wen, Xuefang Xia, Hongmei Li, Kuanzhi Liu, Ligang Zhou, Chaoli Yan, Shuangqing Li, Yiming Li
Publikováno v:
Current Medical Research and Opinion. 36:1107-1115
Objective: DBPR108, a novel dipeptidyl-peptidase-4 inhibitor, has shown great antihyperglycemic effect in animal models. This study was to evaluate the efficacy and safety of DBPR108 monotherapy in...
Autor:
Momoha Koyanagi, Takeshi Imaoka, Tomotaka Shingaki, Aki Yoshikawa, Norika Oki, Kentaro Taki, Soshi Nagaoka, Kenichi Yoshizawa
Publikováno v:
Current Medical Research and Opinion. 36:947-958
Objective: To evaluate the long-term safety and effectiveness of biosimilar insulin glargine (GLY) in real-world clinical practice.Methods: This prospective, non-interventional, multicenter, observ...
Publikováno v:
Current Medical Research and Opinion. 36:749-756
Objective: To determine the pattern of antidiabetic drug use, with a particular focus on the metformin dose, among patients with type 2 diabetes mellitus (T2DM) in a Japanese working population.Met...
Autor:
Takeshi Morimoto, Kazuhiko Sakaguchi, Koichi Kisanuki, Nobuhiro Nishigaki, Akinori Oh, Yukio Shimasaki
Publikováno v:
Current Medical Research and Opinion. 36:387-395
Objective: To explore persistence and adherence with once-daily, twice-daily, or once-weekly DPP-4 inhibitors (DPP-4i) in Japanese patients with type 2 diabetes.Methods: This retrospective, longitu...